incobotulinumtoxinA: all 23 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)RecruitingNCT06293300Phase 2
- A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the ArmCompletedNCT04766723Phase 2Results posted
- Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial LinesCompletedNCT04622254Phase 3Results posted
- Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial LinesCompletedNCT04594213Phase 3Results posted
- Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown LinesCompletedNCT03806933Phase 2Results posted
- "Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic MigraineCompletedNCT03543254Phase 2Results posted
- Kinematic-guided BoNT-A Treatment for ET and PD TremorStatus unknownNCT02427646Phase 2Results posted
- Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual DisabilityCompletedNCT02270736Phase 3Results posted
- NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown LinesCompletedNCT00777803Phase 3Results posted
- Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature EjaculationCompletedNCT07426640Not applicable
- A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)Active, not recruitingNCT07210463Phase 3
- A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United StatesActive, not recruitingNCT07122193Phase 3
- A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the FaceCompletedNCT05784363Phase 1
- A Study of NT 201 Doses in the Treatment of Platysma ProminenceCompletedNCT05773053Phase 2
- BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel SyndromeStatus unknownNCT05411900Phase 2
- Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain InjuryActive, not recruitingNCT03992404Phase 3
- The Effectiveness of Early Botulinum Toxin A Injection for Lower Limbs Spasticity in Subacute Stroke AdultsStatus unknownNCT02505802Phase 4
- Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological DiseasesCompletedNCT02425176Phase 2/3
- Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder SyndromeCompletedNCT01657409Phase 2
- Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing DisordersWithdrawnNCT00773591Phase 2
- Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown LinesCompletedNCT00694148Phase 3
- Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical DystoniaCompletedNCT00541905Phase 4
- Blepharospasm Short IntervalTerminatedNCT00507637Phase 2